Back Bay Life Science Report

Back Bay Life Science Report

Por: Jonathan P. Gertler and Peter Bak
Back Bay Life Science Advisors brings you expert insights from our advisors and investment bankers in the world of BioPharma & MedTech. On this podcast, you’ll hear from our experts in life science development, commercialization, and investment banking, scientific investigators, biotech and medtech executives, physicians, and strategists who excel at guiding global life sciences companies and their investors through complex decisions. Join us for insights generated from in-depth scientific, strategic, and financial analysis at the intersection of science and business.
32 episodios disponibles

Latest episodes of the podcast Back Bay Life Science Report

A Capital Markets Outlook for 2025: 2024, A Year in Review 07/02/2025
The Optimism of Bispecific Antibodies 08/11/2024
Dynamics in Healthcare Focused Markets 30/09/2024
From NASH to MASH: Current Market Dynamics in Hepatology 16/09/2024
Key Considerations for a US Healthcare IPO 22/05/2024
Drug Development in Obesity 30/04/2024
The Current Dynamics in Capital Markets 15/04/2024
Vaccine Developments 2024: A Podcast Discussion on Latest Vaccine Technology and Ongoing Clinical Developments 18/03/2024
Trends and Investment Activity in Radiopharmaceuticals and Psychedelics 14/02/2024
Vertex’s Exa-cel to Biogen and Sage’s Zurzuvae: Notable Product Approvals of 2023 03/01/2024
Monthly Roundup of News from Healthcare Development 07/11/2023
The Current and Future Landscape of Healthcare IPO Markets 27/10/2023
The Heart of the Matter: Behind the Renewed Interest in Cardiovascular Disease 12/10/2023
The Transactional Landscape Of ADCs: The Powerhouse of Antibody Drug Conjugates 29/08/2023
Investing in Health Tech & Digital Medicine: Expert Talk with Mikaela Odlander & Edward Kliphuis 14/04/2023
Contingencies for Biopharma, Medtech Deal Planning in a Down Market 09/02/2023
Gene Editing to Cross-Species Transplantation: The Most Compelling Healthcare Stories of 2022 24/01/2023
Preparing BioPharma and Medtech Companies for Public Listing - Back Bay Life Science Advisors and Nasdaq Nordic 19/09/2022
The Promising Field of Targeted Protein Degraders (TPDs) 30/07/2022
Early Market Access and Pricing with Pete Bak, Christian Thieniel and Brendan Wang 06/07/2022
1 2 Siguiente › Última »
© 2003-2026 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA